GlassScriptPhysician profile
Shannon E Cooke
NPI 1811923063
$2,301.66
in general payments reported to CMS, 2019-2025
15 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.25 · 2020: $37.03 · 2021: $144 · 2022: $1,310 · 2023: $164 · 2024: $76.77 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.13 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,408.97 | 2022-2025 | |
| Arthrex, INC. | $184.95 | 2025 | |
| Smith+Nephew, INC. | $130.93 | 2021 | |
| Depuy Synthes Sales INC. | $126.21 | 2024-2025 | Monovisc |
| Si-Bone, INC. | $125.89 | 2025 | |
| Globus Medical, INC. | $114.63 | 2023 | Distal Radius Plate |
| Pacira Therapeutics, INC. | $41.08 | 2019-2020 | |
| Davol INC. | $30.20 | 2025 | Surgiphor |
| Pacira Pharmaceuticals Incorporated | $25.21 | 2023 | Exparel, Zilretta, Iovera |
| Innovation Technologies INC | $23.77 | 2023 | Irrisept |
| Axogen | $23.60 | 2020 | |
| Bioventus LLC | $20.26 | 2019 | |
| Shockwave Medical, INC | $19.76 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ethicon US, LLC | $13.34 | 2019 | |
| Horizon Therapeutics Plc | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Cooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.